Most people are aware of type 1 and type 2 diabetes, but did you know there is a type 3 diabetes as well! It is a more obscure term. Although it is not an accepted medical diagnosis, type 3 diabetes has been discussed in the literature as a possible relationship between insulin resistance in the brain and Alzheimer's disease. This link has been described to help explain how metabolic disorders impact brain health, causing cognitive decline and dementia.

What is Type 3 Diabetes?

Type 3 diabetes is more of a misnomer because it should not be confused with type 3c diabetes, which relates to pancreatic dysfunction. The term "type 3 diabetes," on the other hand, has been loosely used by some scientists to analogously propose that Alzheimer's disease is strongly implicated with insulin resistance in the brain.

This concept was conceptualized by Dr. Suzanne de la Monte and Dr. Jack Wands of Brown University in the year 2008. This hypothesis postulated that Alzheimer's disease may be called type 3 diabetes for it bears many similarities with glucose metabolism disorder type 2 diabetes. Their concept arises from the basic principle that insulin is fundamental to blood sugar regulation, but it is also the case with the brain. When brain cells become insulin-resistant, they lose access to glucose, impairing their function.

Research published in the Journal of Diabetes Science and Technology supports this hypothesis by indicating that insulin resistance can be a significant contributor to the occurrence of dementia, also referred to as Alzheimer's. The symptoms of memory loss and diminished reasoning are associated with impaired glucose metabolism in the body, especially in the cerebral tissue.

Symptoms of Type 3 Diabetes

Although type 3 diabetes is not a "medical term," its symptoms correlate well with Alzheimer's diseases that are known to reduce the ability to think in an efficient manner and bring down brain health. These signs are:

- Loss of memory, especially short-term.

- Poor judgment and judgment ability

- Failure in recognizing people or places familiar once.

- Failure in the process of reading, writing or processing numbers

- Anxiety, agitation, or mood changes.

- Disorganized thoughts or confusion

- Lack of impulse control

As the disease advances, patients may be afflicted with severe complications including an inability to swallow or control their bodily functions. In the final stages, most patients die from fatal complications such as aspiration pneumonia.

Causes of Type 3 Diabetes

This may not be well understood with regards to type 3 diabetes, or the exact link between insulin resistance and Alzheimer's disease. Some identified contributing factors include the following:

1. Insulin Resistance

Insulin acts as an important regulatory mechanism of brain functions such as memory and cognition. The reduction in insulin signaling may impair metabolism of brain cells, thus bringing about neurodegeneration.

2. Type 2 Diabetes

These diseases show a strong relationship and those individuals diagnosed with type 2 diabetes have double chances of getting Alzheimer's. In the two, the main causes can be chronic inflammation, oxidative stress, and a defect in glucose metabolism.

3. Environmental and Lifestyle Factors

Insulin resistance associated with obesity, stress, and an unhealthy diet is considered a cause that may increase the chances of Alzheimer's disease.

Researches in Frontiers in Neuroscience and The Lancet Neurology have also highlighted that drugs used for antidiabetic medication may be crucial for the prevention or at least slowing down the course of Alzheimer's.

Treatments for Type 3 Diabetes

In 2022, in a study in Pharmaceuticals, researchers studied biomarker uptake in brain regions implicated in the faulty uptake and metabolism of blood sugar in Alzheimer’s patients.

Emerging Therapies

Research into such treatments as intranasal insulin has also been promising. Intranasal delivery of insulin directly to the brain has been reported to enhance glucose uptake by brain cells, improve memory, and boost cognitive performance. While such clinical trials have been shown to be successful, additional research is needed for safety and efficacy.

Medications

For patients being aggressive or agitated, antipsychotic drugs may be prescribed; however, therapies such as cognitive rehabilitation as well as cognitive stimulation therapy serve to preserve memory and executive function.

Lifestyle Interventions

Diet, exercise, and stress management are critical in preventing and managing insulin resistance. A review in the Journal of Alzheimer's Disease also highlighted the benefits of Kirtan Kriya meditation, which can regulate genes involved in insulin and glucose metabolism, improve sleep, and reduce inflammation.

Can Type 3 Diabetes Be Prevented?

Although type 3 diabetes is not officially recognized, its connection to Alzheimer’s disease underscores the importance of proactive measures for brain health. Some prevention strategies include:

1. Healthy Diet

Consuming a balanced diet rich in antioxidants, whole grains, and healthy fats may support brain health.

2. Regular Exercise

Physical activity improves insulin sensitivity, reduces inflammation, and enhances overall metabolic health.

3. Stress Reduction

Mindfulness practices, including meditation, have been shown to lower stress levels, which can reduce the risk of cognitive decline.

The term type 3 diabetes brings out the complex relationship between metabolic disorders and brain health. Even though it is not a recognized medical condition, the concept emphasizes the crucial role of insulin in brain function and its possible contribution to Alzheimer's disease. Continued research will hopefully provide hope for therapies such as intranasal insulin and lifestyle modifications.

A major new study published in the Lancet has found that record numbers of people around the world now have reduced kidney function, a condition known as Chronic Kidney Disease (CKD). This makes CKD one of the most critical public health issues facing the world today.

The number of people struggling with CKD has more than doubled since 1990, jumping from 378 million to a staggering 788 million in 2023. This huge increase is primarily happening because the world's population is both growing and getting older, and CKD is more common in older age.

As a result, CKD is now one of the top 10 causes of death worldwide for the very first time. Approximately 1.5 million people died directly from the condition in 2023. This rapid growth shows just how quickly this disease is spreading and affecting lives globally.

How Does Kidney Affect Other Organ Health?

The study revealed that CKD is dangerous not just because it causes kidney failure, but because it also has a deadly connection to your heart.

Impaired kidney function puts stress on the cardiovascular system and is a key risk factor for heart attacks and strokes, contributing to about 12 percent of all heart disease deaths globally.

Furthermore, the condition severely impacts quality of life, ranking as the 12th leading cause of disability by limiting what people can do. The research also clearly pointed out the three biggest lifestyle and health factors that cause CKD: High Blood Sugar (usually from diabetes), High Blood Pressure, and High Body Mass Index (which is a measure of obesity).

What Are Some Early Signs of Poor Kidney Health?

To ensure you get timely help, it is important to know what some early signs of kidney disease are, according to the National Kidney Foundation.

Less Energy or Trouble Concentrating

A buildup of toxins and waste in your blood, caused by poor kidney function, can make you feel very tired, weak, and may lead to difficulty focusing on tasks or thinking clearly.

Trouble Sleeping

Toxins that are not properly filtered out of the blood by the kidneys can remain in your system, making it difficult to fall asleep or stay asleep throughout the night.

Dry and Itchy Skin

When the kidneys can no longer keep the right balance of minerals and nutrients in the blood, it can lead to mineral and bone disease, causing persistent dry and itchy skin.

Urinating More Frequently

A need to urinate more often than usual, especially late at night, can signal damaged kidney filters, which increases the urge to go. This needs medical checking.

Blood in Urine

Healthy kidneys keep blood cells in the body, but damaged filters allow blood to leak into the urine. This may also indicate an infection or kidney stones.

Foamy Urine

Excessive bubbles or foam in your urine that look like beaten eggs and require multiple flushes to disappear can mean there is a large amount of protein (albumin) leaking into your urine.

Persistent Puffiness Around Eyes

Puffiness, especially around the eyes, is often a sign that your kidneys are damaged and leaking large amounts of protein into the urine instead of keeping it in your body.

Swollen Ankles and Feet

Decreased kidney function can cause your body to hold onto sodium (salt). This excess fluid retention then leads to noticeable swelling in your feet and ankles.

Poor Appetite

A general but important sign, a reduced appetite or feeling of sickness can be caused by the buildup of waste products and toxins in the body due to reduced kidney filtering ability.

Muscle Cramping

Impaired kidney function can lead to an imbalance of essential electrolytes, such as low calcium or poorly controlled phosphorus, which often contributes to painful muscle cramping.

Why Do We Need Early Intervention for Kidney Diseases?

The most hopeful finding is that most people with CKD are still in the early stages of the condition.

This is important because early detection and swift treatment can often prevent the disease from progressing to the point where dialysis or a transplant is needed, which are both dramatic and expensive interventions.

Doctors are urging for more urine testing to catch CKD before symptoms even appear. New medications have also become available in recent years that can slow down the disease and protect the heart.

Ultimately, the report strongly argues that since CKD is currently "underdiagnosed and undertreated," a massive, focused effort is needed globally to make sure patients can afford and access treatment as soon as they are diagnosed.

The World Health Organization’s November 2024 report revealed that chronic obstructive pulmonary disease (COPD) remains the fourth leading cause of death worldwide. The condition was responsible for an estimated 3.5 million deaths in 2021 according to the latest available global data. COPD is a common and serious lung disease, and the WHO noted that smoking, indoor and outdoor pollution, and harmful inhalants are among its most significant triggers.

Children, too, are increasingly at risk due to high pollution levels, secondhand smoke and early-life respiratory infections. With winter pollution worsening across many Indian cities, especially Delhi NCR, experts say this is the right moment to revisit how COPD can be prevented through everyday habits and early interventions.

What COPD Really Is

COPD is identified as a chronic lung disorder that results in persistent breathlessness, chronic cough and long-term mucus production. According to the pulmonologist, the disease is a major global health burden linked to high levels of mortality and long-term disability across populations.

The condition develops slowly and often goes unnoticed in its early stages. Over time, narrowed airways and irreversible lung damage make breathing progressively more difficult. The pulmonologist explained that the air people breathe plays a crucial role in determining long-term lung health, especially for those living in severely polluted areas.

Why COPD Happens

COPD is primarily caused by the inhalation of harmful particles and gases. These include cigarette smoke, secondhand smoke, indoor pollution from biomass fuel, outdoor smog, chemicals, dust and repeated lung infections. The pulmonologist added that a small percentage of COPD cases are due to a rare genetic condition known as alpha-1 antitrypsin deficiency. In such cases, checking family history becomes important for early detection.

Preventing COPD: What Experts Recommend

Preventing COPD requires a comprehensive and consistent lifestyle strategy. While quitting smoking remains the single most effective step for protecting the lungs, the pulmonologist stressed that prevention goes far beyond just avoiding cigarettes. Clean air, healthy food, ideal body weight and regular vaccinations all play a key role.

The pulmonologist shared nine essential tips that can help significantly reduce the risk of COPD, particularly for people living in high-pollution regions such as Delhi NCR.

9 Essential Tips to Prevent COPD

• Avoid smoking completely and seek medical support to quit if necessary.
• Avoid secondhand smoke and maintain distance from people who smoke.
• Reduce indoor pollution by switching from biomass fuels to LPG, keeping windows open for ventilation and using air purifiers when required.
• Limit exposure to outdoor pollution. Wear a mask during high pollution days and stay indoors when air quality is poor. Consider shifting residence or workplace if the area remains persistently polluted.
• Use proper protective gear, including masks, if your profession involves dust, chemicals or industrial fumes.
• Avoid exposure to strong or irritating smells that can trigger respiratory issues.
• Maintain healthy lifestyle practices such as regular exercise and a balanced diet.
• Keep body weight within a healthy BMI range because excess weight worsens breathing and being underweight can increase vulnerability to more severe COPD.
• Ask a doctor about preventive vaccinations such as influenza and pneumococcal shots when appropriate.

A new meta-analysis published in the journal Stroke reports that GLP-1 receptor agonists such as semaglutide may help reduce the risk of ischemic stroke in patients who do not have diabetes. The findings come from a review of preclinical studies and highlight the growing interest in how these widely used drugs may offer benefits beyond blood sugar control.

What GLP-1 Drugs Are and How They Work

GLP-1 receptor agonists are a class of medications that mimic a natural hormone called glucagon-like peptide-1. This hormone helps regulate appetite, insulin release and blood sugar levels. Drugs in this category include semaglutide, liraglutide, exenatide, lixisenatide and dulaglutide. Semaglutide is sold under the brand names Wegovy and Ozempic.

These medicines were originally developed for people with type 2 diabetes. Over time, scientists observed additional effects such as reduced appetite, improved metabolic markers and modest cardiovascular protection. This led to their approval for weight management in people without diabetes. Today, GLP-1 drugs are among the most prescribed medications for obesity and are being studied for heart failure, kidney disease and other conditions. However, their potential benefits in non-diabetic patients at risk of stroke remain largely unexplored.

What the New Review Examined

Researchers from Aarhus University in Denmark conducted the meta-analysis to understand whether GLP-1 drugs could reduce the severity or likelihood of acute ischemic stroke in people who do not have diabetes. The team examined 31 preclinical trials conducted between 2011 and 2024. All studies were carried out in rodent models.

The included drugs were given either orally or through subcutaneous injections. The researchers compared animals receiving GLP-1 drugs with those given a placebo. They reviewed outcomes such as infarct volume, neurological recovery and markers of cell injury.

Findings Show Promising Neuroprotective Effects

Across the studies, animals treated with GLP-1 drugs showed significantly smaller infarct volumes than those given a placebo. They also demonstrated better neurological function after stroke.

Lead author Michael K. Michaelsen from the department of clinical medicine at Aarhus University wrote that the mechanisms behind these benefits are not yet clear. He noted that the effects appear to extend beyond blood sugar regulation. According to the paper, GLP-1 drugs may act on multiple pathways involved in stroke injury including inflammation, oxidative stress and cell death. The authors observed reductions in oxidative stress markers, inflammatory mediators and indicators of cell death in several trials. However, they cautioned that these findings do not prove causality.

Human Impact Still Unknown

Since all the analyzed studies were in animals, experts say it is too early to conclude whether GLP-1 receptor agonists could improve stroke outcomes in non-diabetic patients. Clinical trials will be needed to confirm whether the neuroprotective effects translate to humans.

The authors noted that if future research shows that these drugs do not affect platelet function or clotting during the acute phase of stroke, they could one day be used even before patients undergo neuroimaging. They wrote that early prehospital administration could potentially offer faster protection during the critical first moments of stroke.